Randomized phase III trial comparing docetaxel plus epirubicin versus docetaxel plus capecitabine as first-line treatment in women with advanced breast cancer (Q43244172)
Jump to navigation
Jump to search
scientific article published on 11 November 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized phase III trial comparing docetaxel plus epirubicin versus docetaxel plus capecitabine as first-line treatment in women with advanced breast cancer |
scientific article published on 11 November 2009 |
Statements
1 reference
Randomized phase III trial comparing docetaxel plus epirubicin versus docetaxel plus capecitabine as first-line treatment in women with advanced breast cancer (English)
1 reference
D Mavroudis
1 reference
P Papakotoulas
1 reference
A Ardavanis
1 reference
K Syrigos
1 reference
S Kakolyris
1 reference
N Ziras
1 reference
C Kouroussis
1 reference
N Malamos
1 reference
A Polyzos
1 reference
C Christophyllakis
1 reference
N Kentepozidis
1 reference
V Georgoulias
1 reference
Breast Cancer Investigators of the Hellenic Oncology Research Group
1 reference
11 November 2009
1 reference
1 reference
21
1 reference
1
1 reference
48-54
1 reference
Identifiers
1 reference
1 reference